Literature DB >> 33862214

Excess deaths associated with the Iranian COVID-19 epidemic: A province-level analysis.

Mahan Ghafari1, Alireza Kadivar2, Aris Katzourakis3.   

Abstract

OBJECTIVE: There has been no province-level data on the number of coronavirus disease 2019 (COVID-19)-related deaths in Iran since the start of the pandemic. This study was performed to estimate the number of COVID-19 deaths and population-level exposure per province using seasonal all-cause mortality data.
METHODS: Time-series data were collected from the National Organization for Civil Registration on the seasonal all-cause mortality from spring 2015 to summer 2020 (from March 21, 2015 to September 21, 2020), in accordance with the Solar Hijri (SH) calendar, to estimate the expected number of seasonal deaths for each province using a piecewise linear regression model. A population-weighted infection fatality ratio was then applied to estimate the level of exposure per province during this period.
RESULTS: From the start of winter to the end of summer (from December 22, 2019 to September 21, 2020), there were a total of 58 900 (95% confidence interval 46 900-69 500) excess deaths across all 31 provinces, with 27% (95% confidence interval 20-34%) estimated nationwide exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In particular, Qom and Golestan were among the hardest-hit provinces, with nearly 57% exposure, while another 27 provinces showed significant levels of excess mortality in at least one season with >20% population-level exposure to the virus. Unexpectedly high levels of excess mortality were also detected during fall 2019 (from September 23 to December 21, 2019) across 18 provinces, unrelated and prior to the start of the COVID-19 pandemic.
CONCLUSIONS: This study quantified the pattern of spread of COVID-19 across the country and identified areas with the largest epidemic growth requiring the most immediate interventions.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  COVID-19; Excess mortality; Infection fatality ratio; Iran; SARS-CoV-2

Year:  2021        PMID: 33862214     DOI: 10.1016/j.ijid.2021.04.015

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

1.  A framework for reconstructing SARS-CoV-2 transmission dynamics using excess mortality data.

Authors:  Mahan Ghafari; Oliver J Watson; Ariel Karlinsky; Luca Ferretti; Aris Katzourakis
Journal:  Nat Commun       Date:  2022-05-31       Impact factor: 17.694

2.  Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalized with COVID-19 during the First Five Waves of the Pandemic in Pakistan; Findings and Implications.

Authors:  Kiran Ramzan; Sameen Shafiq; Iqra Raees; Zia Ul Mustafa; Muhammad Salman; Amer Hayat Khan; Johanna C Meyer; Brian Godman
Journal:  Antibiotics (Basel)       Date:  2022-06-09

3.  The impact of COVID-19 Vaccination in Iranian elderly: 7 percent of all-cause deaths reduced by vaccinating 2 percent of population; letter to editor.

Authors:  Sara Jambarsang; Moslem Taheri Soodejani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2022

4.  Machine Learning Models to Predict In-Hospital Mortality among Inpatients with COVID-19: Underestimation and Overestimation Bias Analysis in Subgroup Populations.

Authors:  Javad Zarei; Amir Jamshidnezhad; Maryam Haddadzadeh Shoushtari; Ali Mohammad Hadianfard; Maria Cheraghi; Abbas Sheikhtaheri
Journal:  J Healthc Eng       Date:  2022-06-23       Impact factor: 3.822

5.  Excess all-cause mortality and COVID-19 reported fatality in Iran (April 2013-September 2021): age and sex disaggregated time series analysis.

Authors:  Seyed Amir Ahmad Safavi-Naini; Yeganeh Farsi; Walid Q Alali; Ali Solhpour; Mohamad Amin Pourhoseingholi
Journal:  BMC Res Notes       Date:  2022-04-05

6.  Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran.

Authors:  Maryam Nazemipour; Maryam Shakiba; Mohammad Ali Mansournia
Journal:  Lancet Infect Dis       Date:  2021-02-15       Impact factor: 25.071

7.  Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset.

Authors:  Ariel Karlinsky; Dmitry Kobak
Journal:  Elife       Date:  2021-06-30       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.